AOD 9604 Peptide Therapy in Minneapolis, Minnesota
A physician-guided path to healthy fat metabolism, built into a full nervous-system-first protocol.
Book Your ConsultationStubborn fat rarely responds to diet and exercise alone. Cortisol patterns, metabolic slowdown, and hormone shifts all shape where your body stores fat and how easily it lets go of it. AOD 9604 peptide therapy targets one piece of this picture directly: a fragment of human growth hormone designed to activate fat-burning pathways without raising insulin or IGF-1.
At Mind Body Neurology, our team builds AOD 9604 into a broader integrative neurology framework. Metabolic dysfunction, cortisol imbalance, and nervous system dysregulation feed each other, so a peptide protocol works best paired with an assessment of what is driving the pattern in the first place. Every plan starts with a paid consultation, a review of your metabolic history, and a compounded peptide sourced from an FDA-regulated pharmacy.
Mind Body Neurology sees patients via telehealth in Minnesota, Mississippi, Florida, Georgia, Arkansas, and Tennessee.
On This Page
What Is AOD 9604?
AOD 9604 is a synthetic 16-amino-acid fragment of the C-terminal region of human growth hormone. Researchers isolated this specific segment because it carries the fat-metabolizing signal of full-length growth hormone without the portions responsible for tissue growth or insulin resistance.
In laboratory studies, AOD 9604 increased fat oxidation and lipolysis through the beta-3 adrenergic receptor pathway, producing metabolic effects similar to growth hormone while leaving insulin and IGF-1 levels unchanged.1,2 Six early-phase human trials involving roughly 900 participants established a strong safety profile, though later efficacy trials produced mixed results once rigorous diet and exercise protocols were added to the comparison.3,5
AOD 9604 remains an investigational compound rather than an FDA-approved medication, which is why every protocol at Mind Body Neurology runs under direct physician supervision with pharmacy-compounded product sourced from a regulated pharmacy.
AOD 9604 might fit your case if you notice:
- A metabolism slowed by age or by restrictive dieting
- Fat gain tied to perimenopause or menopause
- Cortisol-driven fat storage around the midsection
- Weight loss plateaus despite consistent diet and exercise
- Joint discomfort tied to excess weight
- Loss of muscle tone alongside fat gain
These signs point to a metabolic pattern worth evaluating, not a diagnosis on their own. A consultation clarifies whether AOD 9604 addresses what is driving your specific case.
How Mind Body Neurology Approaches Peptide Therapy
Full Metabolic and Nervous System Assessment
Before prescribing anything, our clinical team reviews your metabolic labs, cortisol pattern, and nervous system tone. Fat storage rarely comes from one cause, and treating the metabolism alone while ignoring an overactive stress response limits results.
Personalized, Lab-Guided Dosing
Dosing adjusts to your baseline labs, your goals, and how your body responds over the first several weeks. No two patients follow an identical schedule.
Integration With the Full MBN Protocol
AOD 9604 works alongside sleep repair, cortisol regulation, and nutrition guidance rather than as a standalone injection. Patients who address the nervous system pattern driving their metabolism tend to hold their results longer.
How AOD 9604 Works
AOD 9604 activates lipolysis, the process of releasing stored fat from adipose tissue for use as energy. Animal studies show the peptide increases beta-3 adrenergic receptor expression in fat cells, restoring signaling pathways blunted in chronic obesity.1
Unlike full-length growth hormone therapy, AOD 9604 does not raise blood glucose or IGF-1 in the studies conducted to date, the reason clinicians consider it a lower-risk option for patients focused specifically on body composition rather than broader hormone replacement.2,4
What to Expect During Treatment
Most patients follow a six to twelve week protocol using a small subcutaneous injection, timed and dosed to their individual plan. Early changes tend to show up as steadier energy, fewer cravings, and less bloating before visible fat loss becomes apparent.
Our team pairs the peptide with guidance on nutrition timing, sleep, and stress load, since all three influence how efficiently the body uses the metabolic signal AOD 9604 provides.
Safety and Considerations
Across six early human trials, AOD 9604 showed a strong tolerability record, with mild and temporary injection-site reactions the most commonly reported issue.3,4 Because AOD 9604 is investigational rather than FDA-approved for weight loss, treatment happens only through a licensed clinician after a paid consultation and review of your health history.
Patients with active diabetes or significant metabolic disease should have any peptide protocol reviewed alongside their primary care physician or endocrinologist.
Locations Served
Mind Body Neurology sees patients across Minneapolis and Hennepin County, including Bloomington, Edina, Eden Prairie, Plymouth, St. Louis Park, Minnetonka, and Maple Grove, plus telehealth patients throughout Minnesota, Arkansas, Tennessee, Mississippi, Florida, and Georgia.
Stubborn fat rarely resolves in isolation from cortisol, sleep, and nervous system tone. These pieces come together into one plan tailored to your metabolic story.
Book Your ConsultationIs AOD 9604 Right for You?
Good fit:
- Your weight loss has plateaued despite consistent diet and exercise
- You carry cortisol-driven fat around your midsection
- You want a physician-supervised option instead of an unregulated online source
- You are open to pairing peptide therapy with nervous system and lifestyle work
Not ideal:
- You are pregnant, nursing, or trying to conceive
- You have active, uncontrolled diabetes without endocrinology oversight
- You want a standalone quick fix without addressing diet, sleep, or stress
- Emergency or rapidly worsening symptoms of any kind: seek emergency or urgent care first
AOD 9604: Frequently Asked Questions
Still have questions? Book a consultation and get answers specific to your case.
No. AOD 9604 has a strong safety record from early human trials, but it remains an investigational compound rather than an approved weight-loss drug. Treatment at Mind Body Neurology happens under direct physician supervision with pharmacy-compounded product.
Patients self-administer AOD 9604 as a small subcutaneous injection, following a schedule and dose set during your consultation.
Most patients follow a protocol lasting six to twelve weeks. Early changes often show up as steadier energy and fewer cravings before visible fat loss appears.
Human and animal studies to date show AOD 9604 does not raise insulin or IGF-1 levels, unlike full-length growth hormone therapy.
Some patients pair AOD 9604 with other peptides such as CJC-1295 and Ipamorelin as part of a broader protocol. Our clinical team reviews your full peptide plan to avoid overlapping effects.
Peptide consultations and treatment at Mind Body Neurology are paid directly and are not billed through insurance.
Patients who are pregnant, nursing, or managing active uncontrolled diabetes without endocrinology oversight need a different approach. A consultation determines whether AOD 9604 fits your health picture.
References
- Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, Ng FM. "The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice." Endocrinology, 2001. PubMed
- Heffernan MA, Jiang WJ, Thorburn AW, Ng FM. "Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment." International Journal of Obesity and Related Metabolic Disorders, 2001. PubMed
- Stier H, Vos E, Kenley D. "Safety and tolerability of the hexadecapeptide AOD9604 in humans." Journal of Endocrinology and Metabolism, 2013. Journal of Endocrinology and Metabolism
- Moré M, Kenley D. "Safety and metabolism of AOD9604, a novel nutraceutical ingredient for improved metabolic health." Journal of Endocrinology and Metabolism, 2014. Journal of Endocrinology and Metabolism
- Misra M, Kelley DE. "Obesity pharmacotherapy: current perspectives and future directions." Therapeutic Advances in Endocrinology and Metabolism, 2013. PMC
Ready to Address Stubborn Fat at the Root?
Book a paid consultation and find out whether AOD 9604 fits your metabolic picture, alongside the nervous system and lifestyle work supporting your results.
Prescribed only after a medical consultation. Telehealth available in Minnesota and select states.
Email: support@mindbodyneurology.com • Tel: 952-209-6209